Rosen, a leading law firm, encourages cortexyme, inc. investors with losses to inquire about securities class action investigation - crtx

New york, march 15, 2022 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of cortexyme, inc. (nasdaq: crtx) resulting from allegations that cortexyme may have issued materially misleading business information to the investing public. so what: if you purchased cortexyme securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
QNCX Ratings Summary
QNCX Quant Ranking